Operating Income
Operating Income
Edwards Lifesciences Operating Income increased by 216.1% to $477.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.0%, from $394.80M to $477.60M. Over 4 years (FY 2021 to FY 2025), Operating Income shows a downward trend with a -7.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Growth in operating income suggests that the core business is becoming more profitable and efficient.
Detailed definition
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
Peer comparison
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
Metric ID:
operating_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $542.10M | $390.30M | $374.40M | $438.80M | $459.50M | $402.40M | $447.80M | $388.40M | $327.20M | $418.40M | $400.10M | $387.50M | $369.10M | $350.60M | $271.50M | $394.80M | $411.20M | $307.10M | $151.10M | $477.60M |
| QoQ Change | — | -28.0% | -4.1% | +17.2% | +4.7% | -12.4% | +11.3% | -13.3% | -15.8% | +27.9% | -4.4% | -3.1% | -4.7% | -5.0% | -22.6% | +45.4% | +4.2% | -25.3% | -50.8% | +216.1% |
| YoY Change | — | — | — | — | -15.2% | +3.1% | +19.6% | -11.5% | -28.8% | +4.0% | -10.7% | -0.2% | +12.8% | -16.2% | -32.1% | +1.9% | +11.4% | -12.4% | -44.3% | +21.0% |
Range$151.10M – $542.10M
CAGR-2.6%
Avg YoY Growth-6.1%
Median YoY Growth-5.4%
Operating Income at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating income?
- Edwards Lifesciences (EW) reported operating income of $477.60M in Q1 2026.
- How has Edwards Lifesciences's operating income changed year-over-year?
- Edwards Lifesciences's operating income increased by 21.0% year-over-year, from $394.80M to $477.60M.
- What is the long-term trend for Edwards Lifesciences's operating income?
- Over 4 years (2021 to 2025), Edwards Lifesciences's operating income has grown at a -7.0% compound annual growth rate (CAGR), from $1.69B to $1.26B.
- What does operating income mean?
- The profit earned from core business activities, before accounting for interest and taxes.